Schedule of Summarizes Information About Stock Options (Details) (Parenthetical) - shares		12 Months Ended
		Dec. 31, 2022	Dec. 31, 2021
2018 Equity Plan [Member]
Stock options, Granted	[1]	2,365,000	20,000
2018 Equity Plan [Member] | Lucid Diagnostics Inc [Member]
Stock options, Granted		423,300	423,300
Parent Company [Member] | 2014 Equity Plan [Member]
Number of stock options granted. shares		500,854	500,854

[1] Stock options granted under the Lucid Diagnostics Inc. 2018 Equity Plan and those granted outside such plan generally vest ratably over twelve quarters, with the vesting commencing with the grant date quarter-end, and have a ten-year contractual term from date-of-grant.